Role of Daratumumab in Combination With Standard Therapies in Patients With Relapsed and Refractory Multiple Myeloma

Multiple myeloma (MM) is a hematological malignancy characterized by renal insufficiency, bone lesions, anemia, and hypercalcemia. In this modern era of medicine, even with the development of drugs like immunomodulatory agents (IMiDs) and proteasome inhibitors (PI), the treatment of MM prevails as a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2021-06, Vol.13 (6), p.e15440-e15440
Hauptverfasser:	Bapatla, Anusha, Kaul, Arunima, Dhalla, Paramvijay Singh, Armenta-Quiroga, Ana S, Khalid, Raheela, Garcia, Jian, Khan, Safeera
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology Internal Medicine Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!